Lv31
354 积分 2025-12-22 加入
Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
9小时前
求助中
Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
7天前
已关闭
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
21天前
已完结
Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease
21天前
已完结
On the wake of metformin: Do anti-diabetic SGLT2 inhibitors exert anti-aging effects?
1个月前
已完结
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice
1个月前
已完结
Diagnosis and risk factors in pancreatogenic diabetes
1个月前
已关闭
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes
2个月前
已完结
Bioinformatics analysis methods for cell-free DNA
2个月前
已完结
Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes
3个月前
已完结
皖公网安备34019202002308
